These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1871829)
41. Allogeneic bone marrow transplantation: acute and late complications. Tabbara IA Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093 [TBL] [Abstract][Full Text] [Related]
42. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691 [No Abstract] [Full Text] [Related]
43. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases]. Lehrnbecher T Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369 [TBL] [Abstract][Full Text] [Related]
45. Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease. Sullivan KM Clin Exp Immunol; 1996 May; 104 Suppl 1():43-8. PubMed ID: 8625543 [TBL] [Abstract][Full Text] [Related]
46. [Prevention and treatment of various infections after bone marrow transplantation]. Moriyama Y Nihon Rinsho; 1990 Sep; 48(9):2028-34. PubMed ID: 2232207 [No Abstract] [Full Text] [Related]
48. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation. Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529 [TBL] [Abstract][Full Text] [Related]
49. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. Siadak MF; Kopecky K; Sullivan KM Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):53-7. PubMed ID: 8033436 [TBL] [Abstract][Full Text] [Related]
50. Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation. Spitzer TR; Cottler-Fox M; Sullivan P; Lynch M; Tefft MC; Pickle LW; Cirenza E; Cahill R; Deeg HJ; Sacher R Semin Hematol; 1992 Jul; 29(3 Suppl 2):123-6. PubMed ID: 1509292 [No Abstract] [Full Text] [Related]
51. Diminishing morbidity and mortality of bone marrow transplantation. Tutschka PJ Vox Sang; 1986; 51 Suppl 2():87-94. PubMed ID: 3020798 [TBL] [Abstract][Full Text] [Related]
52. Prevention of infections in bone marrow transplant recipients. Serody JS; Shea TC Infect Dis Clin North Am; 1997 Jun; 11(2):459-77. PubMed ID: 9187956 [TBL] [Abstract][Full Text] [Related]
53. Intravenous immunoglobulin in bone marrow transplantation. Gale RP; Winston D Cancer; 1991 Sep; 68(6 Suppl):1451-3. PubMed ID: 1652350 [TBL] [Abstract][Full Text] [Related]
54. Immunoglobulin therapy in bone marrow transplantation. Sullivan KM Am J Med; 1987 Oct; 83(4A):34-45. PubMed ID: 2823602 [TBL] [Abstract][Full Text] [Related]
55. Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation. Elfenbein GJ; Siddiqui T; Rand KH; Graham-Pole J; Marcus RB; Mendenhall NP; Goedert TM; Wikle-Fisher T; Gross SA; Weiner RS Rev Infect Dis; 1990; 12 Suppl 7():S805-10. PubMed ID: 2173109 [TBL] [Abstract][Full Text] [Related]
56. Problems of infection after bone marrow transplantation. Watson JG J Clin Pathol; 1983 Jun; 36(6):683-92. PubMed ID: 6304151 [TBL] [Abstract][Full Text] [Related]
57. Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation. N Engl J Med; 1991 Feb; 324(9):631-3. PubMed ID: 1992325 [No Abstract] [Full Text] [Related]
58. The use of immunoglobulin in bone marrow transplantation. Tutschka PJ J Clin Immunol; 1990 Nov; 10(6 Suppl):88S-92S. PubMed ID: 1964463 [TBL] [Abstract][Full Text] [Related]
59. [Is the administration of immunoglobulins following bone marrow transplantation indicated?]. Klingemann HG Klin Wochenschr; 1987 Sep; 65(18):845-51. PubMed ID: 2822997 [TBL] [Abstract][Full Text] [Related]
60. T-cell recovery following marrow transplant: experience with delayed lymphocyte infusions to accelerate immune recovery or treat infectious problems. Smith FO; Thomson B Pediatr Transplant; 1999; 3 Suppl 1():59-64. PubMed ID: 10587973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]